BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16708354)

  • 41. The association between malignant melanoma and noncutaneous malignancies.
    Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
    Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
    Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
    J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer.
    Hooning MJ; Botma A; Aleman BM; Baaijens MH; Bartelink H; Klijn JG; Taylor CW; van Leeuwen FE
    J Natl Cancer Inst; 2007 Mar; 99(5):365-75. PubMed ID: 17341728
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Second neoplasms in survivors of endometrial cancer: impact of radiation therapy.
    Kumar S; Shah JP; Bryant CS; Awonuga AO; Imudia AN; Ruterbusch JJ; Cote ML; Ali-Fehmi R; Morris RT; Malone JM
    Gynecol Oncol; 2009 May; 113(2):233-9. PubMed ID: 19249081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Descriptive and analytical epidemiology of second primaries in Osaka, Japan].
    Tsukuma H; Tanaka H; Koyama Y; Kinoshita N; Koyama H; Furukawa H
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):1980-7. PubMed ID: 10584561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
    van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
    Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
    Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukaemia (ALL) or non-Hodgkin lymphoma (NHL).
    Steffens M; Beauloye V; Brichard B; Robert A; Alexopoulou O; Vermylen Ch; Maiter D
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):819-27. PubMed ID: 18429947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Gobbi PG; Angrilli F; Brugiatelli M; Musto P; Federico M
    Haematologica; 2008 Sep; 93(9):1335-42. PubMed ID: 18698083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001.
    Andersson M; Jensen MB; Engholm G; Henrik Storm H
    Acta Oncol; 2008; 47(4):755-64. PubMed ID: 18465345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidences and trends of second cancers in female breast cancer patients: a fixed inception cohort-based analysis (United States).
    Yu GP; Schantz SP; Neugut AI; Zhang ZF
    Cancer Causes Control; 2006 May; 17(4):411-20. PubMed ID: 16596293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis.
    Geier D; Hebert B; Potti A
    Anticancer Res; 2002; 22(6B):3797-9. PubMed ID: 12552996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
    De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
    J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer incidence after localized therapy for prostate cancer.
    Moon K; Stukenborg GJ; Keim J; Theodorescu D
    Cancer; 2006 Sep; 107(5):991-8. PubMed ID: 16878323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
    Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
    J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Radiation-induced secondary cancer in patients with uterine carcinoma].
    Arai T; Fukuhisa K; Takeda E; Murata M; Kasamatsu T; Tsunematsu R; Masubuchi K; Fukuda T; Noguchi H; Chihara T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1506-13. PubMed ID: 3089172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Second malignant neoplasms in patients under 40 years of age with laryngeal cancer.
    Albright JT; Karpati R; Topham AK; Spiegel JR; Sataloff RT
    Laryngoscope; 2001 Apr; 111(4 Pt 1):563-7. PubMed ID: 11359120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
    Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
    Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Second cancers among long-term survivors of non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Glimelius B; Holowaty E; Van Leeuwen FE; Lynch CF; Adami J; Gospodarowicz M; Wacholder S; Inskip P
    J Natl Cancer Inst; 1993 Dec; 85(23):1932-7. PubMed ID: 8230284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changing epidemiology and risk factors for gastrointestinal non-Hodgkin's lymphoma in a North American population: population-based study.
    Andrews CN; John Gill M; Urbanski SJ; Stewart D; Perini R; Beck P
    Am J Gastroenterol; 2008 Jul; 103(7):1762-9. PubMed ID: 18557717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.